Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman

被引:5
|
作者
Abou Saleh, Maram [1 ]
Mafiana, Rose Ngozi [2 ]
Al Za'abi, Mohammed [1 ]
Vaishnav, Ragini [1 ]
Al Kindi, Salam [3 ]
Al-Zakwani, Ibrahim [1 ,4 ]
机构
[1] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Dept Pharm, Muscat 123, Oman
[3] Sultan Qaboos Univ, Dept Hematol, Coll Med & Hlth Sci, Muscat, Oman
[4] Gulf Hlth Res, Muscat, Oman
关键词
Febrile neutropenia; Incidence; Length of hospital stay; Neutropenia; Oman; FEBRILE NEUTROPENIA; CANCER-PATIENTS; IMPACT;
D O I
10.1007/s11096-013-9859-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Little is known about the incidence and burden of chemotherapy-induced neutropenia (CIN) in Oman or the Arabian Gulf. Objectives To determine the epidemiology of CIN at Sultan Qaboos University Hospital in Oman. Methods A retrospective observational study of all eligible CIN episodes in adult (> 18 years) patients with solid tumors and hematological malignancies at Sultan Qaboos University Hospital (SQUH) from January to December 2010. Analyses were performed using univariate statistics. Results A total of 1,357 episodes in 159 patients with a mean age of 50 +/- A 15 years (19-91) were evaluated. Fifty-four percent (n = 86) of the patients were female. A total of 46 % (73/159) of the patients developed CIN accounting for 15 % (210/1,357) of all episodes. Twelve percent (25/210) of these CIN episodes were associated with fever in 26 % (19/73) patients. There was significant association between CIN and chemotherapy regimen (P < 0.001), younger age (P < 0.001), low hemoglobin (Hb) levels (P < 0.001) and advanced cancer stage (P = 0.006). Conclusions This study suggests a high incidence of CIN in SQUH patients which resulted in chemotherapy delays, longer hospital stays, and inpatient mortality. CIN was significantly correlated with chemotherapy regimen, younger age, low Hb levels and cancer stage.
引用
收藏
页码:1036 / 1039
页数:4
相关论文
共 50 条
  • [21] FLUCONAZOLE FOR ANTIFUNGAL PROPHYLAXIS IN CHEMOTHERAPY-INDUCED NEUTROPENIA
    PRESTON, SL
    BRICELAND, LL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (02) : 164 - 173
  • [22] Risk models for predicting chemotherapy-induced neutropenia
    Lyman, GH
    Lyman, CH
    Agboola, O
    ONCOLOGIST, 2005, 10 (06): : 427 - 437
  • [23] LITHIUM-CARBONATE IN CHEMOTHERAPY-INDUCED NEUTROPENIA
    MEISLER, AI
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (21): : 1179 - 1180
  • [24] Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia
    Ratti, Margherita
    Tomasello, Gianluca
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 15 - 24
  • [25] PROTECTION FROM CHEMOTHERAPY-INDUCED NEUTROPENIA BY IMUVERT
    JIMENEZ, JJ
    HUSSEIN, AM
    HINDAHL, M
    PEARSON, FC
    YUNIS, AA
    CLINICAL RESEARCH, 1991, 39 (02): : A171 - A171
  • [26] Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
    Rofail, Pierre
    Tadros, Mariam
    Ywakim, Riham
    Tadrous, Mina
    Krug, Allison
    Cosler, Leon E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 699 - 709
  • [27] Protease inhibitors potentiate chemotherapy-induced neutropenia
    Bower, M
    McCall-Peat, N
    Ryan, N
    Davies, L
    Young, AM
    Gupta, S
    Nelson, M
    Gazzard, B
    Stebbing, J
    BLOOD, 2004, 104 (09) : 2943 - 2946
  • [28] PROTECTION FROM CHEMOTHERAPY-INDUCED NEUTROPENIA BY IMUVERT
    JIMENEZ, JJ
    HUANG, HS
    HINDAHL, M
    PEARSON, FC
    YUNIS, AA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02): : 83 - 85
  • [29] Phlegmonous gastritis in a patient with chemotherapy-induced neutropenia
    Cautures, Eugenio
    Chiocca, Octavio e.
    Orellano, MARiA A. N. T. O. N. E. L. A.
    Ibarzabal, Juan ignacio
    Pendino, Juan carlos
    Bettini, Lisandro r.
    MEDICINA-BUENOS AIRES, 2025, 85 (01) : 234 - 238
  • [30] Hematopoietic growth factors for chemotherapy-induced neutropenia
    Yalçin, S
    CANCER INVESTIGATION, 1999, 17 (07) : 555 - 555